BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34830749)

  • 1. High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis.
    Thakur N; Yim K; Abdul-Ghafar J; Seo KJ; Chong Y
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
    Orme JJ; Taza F; De Sarkar N; Tewari AK; Arsalan Naqvi S; Riaz IB; Childs DS; Omar N; Adra N; Ashkar R; Cheng HH; Schweizer MT; Sokolova AO; Agarwal N; Barata P; Sartor O; Bastos D; Smaletz O; Berchuck JE; McClure H; Taplin ME; Aggarwal R; Sternberg CN; Vlachostergios PJ; Alva AS; Mehra N; Nelson PS; Hwang J; Dehm SM; Shi Q; Fleischmann Z; Sokol ES; Elliott A; Huang H; Bryce A; Marshall CH; Antonarakis ES
    Eur Urol Oncol; 2023 Dec; ():. PubMed ID: 38072760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of poly (adenosine diphosphate[ADP]-ribose) polymerase expression and prognosis in ovarian cancer: A systematic review and meta-analysis.
    Zhang J; Wei Z; Zhang Z
    J Gynecol Obstet Hum Reprod; 2022 Apr; 51(4):102344. PubMed ID: 35218983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials.
    Shao F; Liu J; Duan Y; Li L; Liu L; Zhang C; He S
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32096544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.
    Schettini F; Giudici F; Bernocchi O; Sirico M; Corona SP; Giuliano M; Locci M; Paris I; Scambia G; De Placido S; Rescigno P; Prat A; Curigliano G; Generali D
    Eur J Cancer; 2021 May; 149():134-152. PubMed ID: 33862496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude of benefit of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for malignant tumor: A meta-analysis.
    Gu L; Du N; Jin Q; Li S; Xie L; Mo J; Shen Z; Mao D; Ji J; Khadaroo PA; Chen B
    Crit Rev Oncol Hematol; 2020 Mar; 147():102888. PubMed ID: 32018126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis.
    Qiao W; Pan L; Kou C; Li K; Yang M
    PLoS One; 2017; 12(2):e0172413. PubMed ID: 28212434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for ovarian cancer: a systematic review and meta-analysis.
    Yang Y; Du N; Xie L; Jiang J; Mo J; Hong J; Mao D; Ng DM; Shi H
    World J Surg Oncol; 2020 Jul; 18(1):151. PubMed ID: 32622363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors as maintenance therapy in women with newly diagnosed ovarian cancer: a systematic review and meta-analysis.
    Cheng H; Yang J; Liu H; Xiang Y
    Arch Gynecol Obstet; 2021 Aug; 304(2):285-296. PubMed ID: 34021367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis.
    Sun M; Du M; Zhang W; Xiong S; Gong X; Lei P; Zha J; Zhu H; Li H; Huang D; Gu X
    Front Endocrinol (Lausanne); 2019; 10():121. PubMed ID: 30930849
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
    Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
    J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis.
    Ding P; Chen P; Ouyang J; Li Q; Li S
    Front Oncol; 2023; 13():1242231. PubMed ID: 37664060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in
    Wang J; Zhang Y; Yuan L; Ren L; Zhang Y; Qi X
    Aging (Albany NY); 2020 Nov; 13(1):450-459. PubMed ID: 33257598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysis.
    Zhu H; Zhao S; Jiao R; Wang H; Tang R; Wu X; Wang F; Ge X; Li Q; Miao L
    Cancer Cell Int; 2020; 20():304. PubMed ID: 32675944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of miR17-92 family in patients with digestive system cancers: a systematic review and meta-analysis.
    Zhang X; Zhang S; He Q; Gao X; Yang L; Xu P; Zhao R; Wang Q; Zhang L; Zhao P
    Cancer Manag Res; 2019; 11():1043-1058. PubMed ID: 30774432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between LKB1 expression and prognosis of patients with solid tumours: an updated systematic review and meta-analysis.
    Ren YH; Zhao FJ; Mo HY; Jia RR; Tang J; Zhao XH; Wei JL; Huo RR; Li QQ; You XM
    BMJ Open; 2019 Aug; 9(8):e027185. PubMed ID: 31383697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis.
    Li J; Cui Z; Li H; Lv X; Gao M; Yang Z; Bi Y; Zhang Z; Wang S; Zhou B; Yin Z
    Cancer Cell Int; 2018; 18():109. PubMed ID: 30093838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis.
    Qiao GL; Qi WX; Jiang WH; Chen Y; Ma LJ
    Onco Targets Ther; 2016; 9():1889-97. PubMed ID: 27099520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas.
    Xu P; Zhao Y; Liu K; Lin S; Liu X; Wang M; Yang P; Tian T; Zhu YY; Dai Z
    Cancer Manag Res; 2017; 9():821-837. PubMed ID: 29276405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.